REGENXBIO Inc. (RGNX): Shareholders' Equity
$102.73M
As of 2025-12-31
$71.77M
As of 2026-06-30
-41.6%
3-year compound annual growth
-22.9%
5-year compound annual growth
-7.2%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $102.73M | -60.4% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $259.65M | -16.7% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $311.74M | -39.6% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $516.20M | -32.5% | 2025-03-13, Balance as of period end |
| 2021-12-31 | $764.30M | +102.3% | 2024-02-27, Balance as of period end |
| 2020-12-31 | $377.75M | -16.1% | 2023-02-28, Balance as of period end |
| 2019-12-31 | $450.20M | -11.5% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $508.85M | +178.0% | 2021-03-01, Balance as of period end |
| 2017-12-31 | $183.03M | +13.2% | 2020-02-26, Balance as of period end |
| 2016-12-31 | $161.74M | -25.4% | 2019-02-27, Balance as of period end |
| 2015-12-31 | $216.81M | n/m | 2018-03-06, Balance as of period end |
| 2014-12-31 | -$18.29M | n/m | 2017-03-07, Balance as of period end |
| 2013-12-31 | -$13.92M | n/a | 2016-03-03, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $102.73M | -60.4% |
| Ginkgo Bioworks Holdings, Inc. (DNA) | 2025-12-31 | $508.59M | -29.0% |
| Adaptimmune Therapeutics PLC (ADAPY) | 2024-12-31 | $11.85M | -70.0% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $1.24B | +68.8% |
| Monte Rosa Therapeutics, Inc. (GLUE) | 2025-12-31 | $233.06M | +4.5% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $87.80M | +49.0% |
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | -$38.50M | n/m |
| Agenus Inc (AGEN) | 2025-12-31 | -$271.11M | n/m |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | -$500.47M | n/m |
Compare RGNX, DNA, ADAPY, BEAM side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗